Clinical trial
Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients
NCT01744431 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Thrombin Generation Measurement Predict the Risk of Venous Thromboembolism in Acute Ill Patients
- Lead sponsor
- HaEmek Medical Center, Israel
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2012
- Completion date
- September 30, 2013
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.